期刊全名
NATURE MEDICINE
最新影响因子
58.7年均收录文章
157期刊简称
NAT MED来源地区
UNITED STATES详细类别
CELL BIOLOGY细胞生物学
1区
MEDICINE
RESEARCH & EXPERIMENTAL医学：研究与实验
1区
BIOCHEMISTRY & MOLECULAR BIOLOGY生化与分子生物学
1区
中科院杂志分区
医学(1区)是否OA开放访问
No投稿难度
约15%出版周期
Monthly投稿链接
点击投稿杂志主页
点击查看杂志主页自引率
1.40%类别
医学-生化与分子生物学coverage
Science Citation Index审稿周期
平均1.0个月《Nature Medicine》是一本国际知名的医学期刊，ISSN号为1078-8956，由Springer Nature出版集团出版，出版地为英国伦敦，出版周期为月刊。该期刊的影响因子较高，常年位居医学领域前列，属于非开放获取（非OA）期刊，被SCI收录，并且在中科院分区中通常位列医学大类的一区。其发文特点聚焦于生物医学领域的重大突破和前沿研究，涵盖基础医学、临床医学、转化医学等多个方向，尤其注重具有临床意义的原创性研究。杂志以高质量的审稿标准和严格的学术要求著称，发表的研究通常具有较高的创新性和影响力，但投稿竞争激烈，拒稿率较高，对研究设计的严谨性和数据的完整性要求极为严格，因此投稿者需确保研究具备足够的深度和广度。总体而言，《Nature Medicine》是医学领域的顶级期刊，但投稿风险较大，适合具有突出成果的研究团队。
RANO criteria for response assessment of brain metastases based on amino acid PET imaging
2025-05-08T14:02:39Z
The trials that could transform treatment for serious liver disease
2025-05-07T10:22:32Z
Cardiac and liver impairment on multiorgan MRI and risk of major adverse cardiovascular and liver events
2025-05-07T09:02:18Z
PD-L1 and the dawn of modern cancer immunotherapy
2025-05-05T09:02:43Z
Targeting blood pressure to protect the brain
2025-05-02T11:02:14Z
Modeling the impact of vaccine campaigns on the epidemic transmission dynamics of chikungunya virus outbreaks
2025-05-01T09:03:28Z
Infant mental health services for birth and foster families of maltreated pre-school children in foster care (BeST?): a cluster-randomized phase 3 clinical effectiveness trial
2025-05-01T09:02:45Z
The quandary of high-quality evaluation in complex child welfare systems
2025-05-01T09:02:45Z
Low-voltage-area ablation for persistent atrial fibrillation: a randomized controlled trial
2025-04-30T09:03:10Z
Author Correction: Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury
2025-04-30T11:02:38Z
Antibiotics reduce vaccine responses in infants
2025-05-02T11:10:41Z
Transmission through a heavy-tailed sexual contact network explains the New York City mpox outbreak
2025-04-30T09:04:07Z
Progress with stem cell therapy in Parkinson’s disease
2025-05-02T11:02:10Z
Promoting transparency in AI for biomedical and behavioral research
2025-04-30T09:04:12Z
Precision nutrition for cardiometabolic diseases
2025-04-30T09:04:55Z
Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial
2025-04-29T12:03:36Z
D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial
2025-04-29T09:04:30Z
SPIRIT 2025 statement: updated guideline for protocols of randomized trials
2025-04-28T22:03:11Z
Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis
2025-04-29T09:04:48Z
The stochasticity of biological aging
2025-04-29T09:04:38Z
